Companies on Multiple Myeloma in Europe

Published within

« | 1 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Genmab A/S

Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is on the areas of cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 179 people as of December 31, 2011.

Published By MarketLine
21 Jan 2013 $175
Buy

« | 1 | » »|

No help is available.